Yarlagadda V - Search Results

1

Resistance-Guided Discovery of Elfamycin Antibiotic Producers with Antigonococcal Activity.

Yarlagadda V, Medina R, Johnson TA, Koteva KP, Cox G, Thaker MN, Wright GD. Yarlagadda V, et al. ACS Infect Dis. 2020 Dec 11;6(12):3163-3173. doi: 10.1021/acsinfecdis.0c00467. Epub 2020 Nov 7. ACS Infect Dis. 2020. PMID: 33164482

2

A Screen of Natural Product Extracts Identifies Moenomycin as a Potent Antigonococcal Agent.

Yarlagadda V, Rao VN, Kaur M, Guitor AK, Wright GD. Yarlagadda V, et al. ACS Infect Dis. 2021 Jun 11;7(6):1569-1577. doi: 10.1021/acsinfecdis.1c00040. Epub 2021 Apr 7. ACS Infect Dis. 2021. PMID: 33826296

3

Membrane-Active Rhamnolipids Overcome Aminoglycoside Resistance.

Yarlagadda V, Wright GD. Yarlagadda V, et al. Cell Chem Biol. 2019 Oct 17;26(10):1333-1334. doi: 10.1016/j.chembiol.2019.09.015. Cell Chem Biol. 2019. PMID: 31626780 Free article.

4

Venturicidin A, A Membrane-active Natural Product Inhibitor of ATP synthase Potentiates Aminoglycoside Antibiotics.

Yarlagadda V, Medina R, Wright GD. Yarlagadda V, et al. Sci Rep. 2020 May 18;10(1):8134. doi: 10.1038/s41598-020-64756-0. Sci Rep. 2020. PMID: 32424122 Free PMC article.

5

Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.

Yarlagadda V, Manjunath GB, Sarkar P, Akkapeddi P, Paramanandham K, Shome BR, Ravikumar R, Haldar J. Yarlagadda V, et al. ACS Infect Dis. 2016 Feb 12;2(2):132-9. doi: 10.1021/acsinfecdis.5b00114. Epub 2015 Nov 30. ACS Infect Dis. 2016. PMID: 27624964

6

Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens.

Yarlagadda V, Sarkar P, Samaddar S, Manjunath GB, Mitra SD, Paramanandham K, Shome BR, Haldar J. Yarlagadda V, et al. ACS Infect Dis. 2018 Jul 13;4(7):1093-1101. doi: 10.1021/acsinfecdis.8b00011. Epub 2018 May 14. ACS Infect Dis. 2018. PMID: 29726673

7

Vancomycin Derivative Inactivates Carbapenem-Resistant Acinetobacter baumannii and Induces Autophagy.

Sarkar P, Samaddar S, Ammanathan V, Yarlagadda V, Ghosh C, Shukla M, Kaul G, Manjithaya R, Chopra S, Haldar J. Sarkar P, et al. Among authors: yarlagadda v. ACS Chem Biol. 2020 Apr 17;15(4):884-889. doi: 10.1021/acschembio.0c00091. Epub 2020 Mar 27. ACS Chem Biol. 2020. PMID: 32195571

8

Tackling vancomycin-resistant bacteria with 'lipophilic-vancomycin-carbohydrate conjugates'.

Yarlagadda V, Konai MM, Manjunath GB, Ghosh C, Haldar J. Yarlagadda V, et al. J Antibiot (Tokyo). 2015 May;68(5):302-12. doi: 10.1038/ja.2014.144. Epub 2014 Oct 29. J Antibiot (Tokyo). 2015. PMID: 25351946

9

Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria.

Yarlagadda V, Samaddar S, Paramanandham K, Shome BR, Haldar J. Yarlagadda V, et al. Angew Chem Int Ed Engl. 2015 Nov 9;54(46):13644-9. doi: 10.1002/anie.201507567. Epub 2015 Oct 16. Angew Chem Int Ed Engl. 2015. PMID: 26473305

10

Membrane active vancomycin analogues: a strategy to combat bacterial resistance.

Yarlagadda V, Akkapeddi P, Manjunath GB, Haldar J. Yarlagadda V, et al. J Med Chem. 2014 Jun 12;57(11):4558-68. doi: 10.1021/jm500270w. Epub 2014 May 20. J Med Chem. 2014. PMID: 24846441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters